Compare AdaptHealth Corp (AHCO) vs Berkshire Hathaway Inc Class B (BRK.B) Price & Performance

AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.

The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.

BRK.B trades at $495.03, down 2.3% today, with a bullish technical signal from moving averages but neutral oscillators. Analyst consensus is positive with 57% buy ratings. Key support lies at $494, with resistance at $509. The stock's fundamental metrics are not fully available in the provided data, requiring external verification for a complete view.

The outlook is cautiously optimistic given strong analyst support and bullish technical trends, though the absence of recent financial ratios and news necessitates careful monitoring of upcoming earnings and market conditions for confirmation of growth prospects and risk assessment.